IPO watch

French coronary stent play Stentys S.A. unveiled plans to go public on Euronext Paris in an IPO that will fund the European rollout of its self-expanding stent for patients with acute myocardial infarction (AMI).

On Wednesday, the company said it plans to sell 1.9 million shares at €10.80-€13.20 in an IPO and an ex-U.S. private placement. A €12 price would raise €22.7 million ($31.7 million) and value Stentys at €87 million ($121.3 million) based on 7.2 million shares outstanding...